itraconazole and Chronic Disease

itraconazole has been researched along with Chronic Disease in 105 studies

Research

Studies (105)

TimeframeStudies, this research(%)All Research%
pre-19903 (2.86)18.7374
1990's29 (27.62)18.2507
2000's33 (31.43)29.6817
2010's34 (32.38)24.3611
2020's6 (5.71)2.80

Authors

AuthorsStudies
Agarwal, R; Aggarwal, AN; Chakrabarti, A; Choudhary, H; Dhooria, S; Garg, M; Muthu, V; Prasad, KT; Sehgal, IS1
Faizal, B; Joy, N; Salil, A1
Bosch-Nicolau, P; Burgos, J; Molina, I; Salvador, F; Sánchez-Montalvá, A; Sulleiro, E1
Apolot, D; Bongomin, F; Katende, A; Kirenga, BJ; Kwizera, R; Teu, A; Worodria, W1
Samaddar, A; Sharma, A; Shrimali, T1
Bongomin, F; Denning, DW; Garcez, T1
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y1
Akitti, T; Côrtes, JG; Cuzzi, T; Fernandes, NC; Quintella, DC1
Agarwal, R; Agarwal, S; Gupta, S; Gupta, V; Sahoo, AK; Singh, G; Xess, I1
Li, R; Wang, R; Wang, X1
Gomi, T; Horino, T; Kamei, K; Miyagawa, S; Onda, A; Yaguchi, H1
Bongomin, F; Denning, DW; Harris, C; Hayes, G; Kosmidis, C1
Ashrafi-Khozani, M; Falahati, M; Farahyar, S; Heidarie-Kohan, F; Majdabadi, N; Mohammadnejad, S; Rahimi-Moghaddam, P; Razavi, T1
Bassas, J; Bielsa, I; Fernández-Rivas, G; Ferrándiz, C; Jaka, A; Richarz, NA1
Fujimura, M; Makimura, K; Ogawa, H; Tone, K1
Agarwal, R; Aggarwal, AN; Chakrabarti, A; Garg, M; Gupta, D; Vishwanath, G1
Eom, JS; Jeon, K; Jhun, BW; Koh, WJ; Kwon, OJ; Lee, JH; Suh, GY1
Hishiya, N; Kasahara, K; Maeda, K; Matsumoto, K; Mikasa, K; Morita, K; Nario, K; Ogawa, T; Tsujimoto, K; Uno, K; Yamada, Y1
de Jesús Fernández-Alonso, A; Flores-Franco, RA; Gómez-Díaz, A1
Ebenezer, J; Maheswaran, S; Mathews, SS; Rupa, V1
Dabó, H; Gomes, I; Marinho, A1
Abbas, MA; Ahmed, SA; Al-Hatmi, AM; de Hoog, GS; Jouvion, G; Kolecka, A; Mahgoub, el S1
Fischer, G; Lee, A; Nguyen, Y1
Develoux, M1
Borish, L; Kennedy, JL; Liu, L; Negri, J; Payne, SC; Steinke, JW1
Jeon, K; Jhun, BW; Koh, WJ; Lee, H; Lee, SY; Moon, SM; Park, HY1
Ito, A; Kiyokawa, H; Nakashima, R; Suzuki, Y; Takafuji, S1
Jakopović, M; Mazuranić, I; Miculinić, N; Plestina, S; Redzepi, G; Samarzija, M; Srdić, D1
Manohar, A; Nizlan, MN1
Lal, D; Stankiewicz, JA1
Concepción, JL; Lanza, G; Márquez, E; Paniz-Mondolfi, AE; Pérez-Alvarez, AM1
Fujimura, M; Makimura, K; Ogawa, H; Takeuchi, Y1
Badali, H; Cameo, MI; De Hoog, GS; Najafzadeh, MJ; Revillo, MJ; Rezusta, A; Yus, MC; Zubiri, ML1
Kato, T; Ohnishi, R; Sano, K; Suzuki, T; Yasuda, S1
Imamura, Y; Ishimatsu, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Miyazaki, T; Mukae, H; Nagayasu, T; Nakano, K; Sakamoto, N; Seki, M; Tagawa, T; Tsuchiya, T; Yamamoto, K; Yamamoto, Y; Yamasaki, N; Yanagihara, K1
Ghibaudo, G; Peano, A1
Kauffman, CA; Smith, JA1
Addidle, M; Grimwade, K; Kasuga, T; Pynn, J; Skellern, P1
Cano, LE; Diaz-Granados, LR; Duque, JJ; Lopera, DE; Naranjo, TW; Restrepo, A1
Baxter, CG; Denning, DW; Felton, TW; Marshall, A; Roberts, M1
Joseph, NM; Pradeepkumar, NS1
Bernabeu-Wittel, J; Conejo-Mir, J; Gómez Gómez, MJ; Lorente-Lavirgen, AI1
Fujii, H; Hayashi, M; Kaneda, T; Kaneko, M; Karino, T; Kida, Y; Suzuki, Y; Tada, K; Tomii, K; Tomioka, H1
Di MartinoOrtiz, B; Rodríguez-Masi, M; Rodríguez-Oviedo, ML1
Das, S; Gupta, N; Jain, S; Malik, JN1
Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC1
Meneses-García, A; Morales-de la Luz, R; Mosqueda-Taylor, A; Rivera, LM1
Anyanwu, EC; Campbell, AW; Vojdani, A1
Apt, W; Honores, P; López, B; Ortiz, S; Osuna, A; Rojas, A; Sánchez, G; Solari, A; Zulantay, I1
Brochhagen, HG; Chemnitz, J; Cornely, OA; Hübel, K1
Krause, M; Moll, C; Röthlin, M; Thurnheer, R1
Goodman, S; Werle, J1
Klein, AM; Lafreniere, D; Tiu, C1
Jiang, ZF; Xu, SY; Zhao, SY1
Apt, W; Arribada, A; Coronado, X; Gil, LC; Mundaca, K; Osuna, A; Rodríguez, J; Sánchez, G; Solari, A; Zulantay, I1
Bush, D; Gotoff, R; Llinas, L; Olenginski, TP; Weber, V1
Brooks, HL; Newell, CK; Steinmetz, RL1
Verma, SB1
Denning, DW; Dupont, B; Lode, H; Sambatakou, H1
Fujii, M; Kato, M; Kawabata, A; Sugino, Y; Yagi, A1
Blignaut, E; Botes, ME; Nieman, HL1
Choi, JH; Choi, SM; Lee, DG; Min, WS; Park, SH; Shin, WS; Yoo, JH1
Homma, S; Izumikawa, K; Kawabata, M; Kishi, K; Miyamoto, A; Ohtsu, Y; Sakamoto, S; Takaya, H; Tsuboi, E; Yoshimura, K1
Daudia, A; Jones, NS1
Kaplan, B; Nathansohn, N; Shemer, A; Trau, H1
Borisov, I; Dimitrov, R; Doganov, N; Iarŭkov, A; Raĭcheva, I; Vasilev, N; Veltova, L1
Aguilera, X; Apt, P; Apt, W; Arribada, A; Cortés, P; Miranda, C; Pérez, C; Rodríguez, J; Zulantay, I1
Dubois, AE; Kauffman, HF; Koeter, GH; Latge, JP; Tomee, JF; van der Werf, TS1
Kanazawa, M; Kawashiro, T; Nakamura, H; Naoki, K; Suzuki, Y; Terashima, T1
Caras, WE; Pluss, JL1
Ikeda, Y; Kurasawa, T; Matsuo, H; Matsushita, Y; Nakatani, K; Sato, A; Yamadori, H1
DeHart, DJ1
Czaika, V; Hopp, M; Kunzelmann, V; Rossner, D; Schmalreck, A; Sterry, W; Tietz, HJ1
Hazen, KC; Hughs, E; Kolmer, HL; Platts-Mills, TA; Taketomi, EA; Wilson, BB1
Nalepa, P; Pajor, A; Sidorowicz, M1
Kutbi, S; Smith, EL1
Ferro, TJ; Futerfas, R; Phelps, DT; Saraceno, JL; Schwartz, DB1
Bruno, R; Calderon, W; Filice, G; Malfitano, A; Parisi, A; Patruno, SF; Sacchi, P1
Byrd, RP; Ramirez, J; Roy, TM1
Apt, W; Díaz, E; Sánchez, G; Solari, A; Venegas, J; Zulantay, I1
Apt, W; Rodríguez, J; Sánchez, G; Venegas, J; Zulantay, I1
Aguilera, X; Apt, W; Arribada, A; Cortés, P; Juri, D; Miranda, C; Pérez, C; Rodriguez, J; Sánchez, G; Zulantay, I1
Aznar, C; Carme, B; Clyti, E; Couppie, P; Huerre, M; Lemoine, C; Pradinaud, R; Sainte-Marie, D1
Ewig, S; Gillissen, A; Layer, G; Schäfer, H; Tasci, S1
Fukuda, M; Iizuka, T; Kume, H; Mochizuki, M; Murase, S; Shimada, S; Takahashi, K1
Arrese, JE; Piérard, GE; Piérard-Franchimont, C1
Darras, A; Demory, JL; Jaggi, F; Mulliez, P; Smith, M1
Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ1
Morris, DL1
Fadl, FA; Faizuddin, M; Hassan, KM1
Brady, RC; Sommerkamp, TG1
Colombo, MD; Ghetti, E; Piraccini, BM; Tosti, A1
Lamey, PJ; Lewis, MA; Samaranyake, LP1
Merkus, JM; Van Heusden, AM2
Denning, DW; Dupont, B; Stevens, DA; Tucker, RM1
Gomez, I; Munera, MI; Naranjo, MS; Restrepo, A; Restrepo, P; Trujillo, M1
Defaveri, J; Graybill, JR1
Clayton, YM; Hay, RJ; Midgely, G; Moore, MK1
Arathoon, EG; Denning, DW; Rinaldi, MG; Stevens, DA; Tucker, RM1
Dupont, B1
Cumming, D; Elliott, JA; Milne, LJ1
Jacquemin, JL; Lacroix, C; Rabot, MH; Rovira, JC; Villard, C1
Blatchford, N; Cauwenbergh, G; Chwetzoff, E; Daunas, J; De Beule, K; De Doncker, P; Koster, M; Legendre, R1

Reviews

11 review(s) available for itraconazole and Chronic Disease

ArticleYear
Pulmonary infection due to Acrophialophora fusispora in a patient with underlying mixed connective tissue disease and chronic pulmonary aspergillosis: A case report and review of literature.
    Journal de mycologie medicale, 2020, Volume: 30, Issue:2

    Topics: Antifungal Agents; Ascomycota; Chronic Disease; Coinfection; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mixed Connective Tissue Disease; Opportunistic Infections; Pulmonary Aspergillosis

2020
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea

2022
Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
    Mycoses, 2013, Volume: 56, Issue:5

    Topics: Adult; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Itraconazole; Male; Prospective Studies; Pulmonary Aspergillosis; Radiography, Thoracic; Treatment Outcome

2013
[Mycetoma and their treatment].
    Journal de mycologie medicale, 2016, Volume: 26, Issue:2

    Topics: Actinobacteria; Antifungal Agents; Chronic Disease; Humans; Itraconazole; Mycetoma; Trimethoprim, Sulfamethoxazole Drug Combination

2016
Blastomycosis.
    Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Blastomyces; Blastomycosis; Central Nervous System Infections; Chronic Disease; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Radiography; Respiratory Distress Syndrome; Sensitivity and Specificity; Skin Ulcer

2010
Chronic coccidioidomycosis infection of the knee: a case report.
    American journal of orthopedics (Belle Mead, N.J.), 2004, Volume: 33, Issue:8

    Topics: Antifungal Agents; Arthritis, Infectious; Chronic Disease; Coccidioidomycosis; Humans; Itraconazole; Knee; Male; Middle Aged; Orthopedic Procedures; Recurrence; Reoperation

2004
Advances in management of paranasal sinus aspergillosis.
    The Journal of laryngology and otology, 2008, Volume: 122, Issue:4

    Topics: Acute Disease; Antifungal Agents; Aspergillosis; Chronic Disease; Humans; Itraconazole; Respiratory Hypersensitivity; Sinusitis; Tomography, X-Ray Computed

2008
Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma.
    American journal of respiratory and critical care medicine, 1995, Volume: 151, Issue:1

    Topics: Adult; Antibodies, Fungal; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Disease Progression; Humans; Immunoglobulin G; Itraconazole; Lung; Lung Diseases, Fungal; Male; Monitoring, Immunologic; Recurrence; Tomography, X-Ray Computed

1995
Chronic necrotizing pulmonary aspergillosis: approach to management.
    Chest, 1997, Volume: 112, Issue:2

    Topics: Aged; Algorithms; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Necrosis; Pneumonectomy; Prognosis; Risk Factors; Treatment Outcome

1997
Diagnosis and treatment of oral candidosis.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1991, Volume: 49, Issue:9

    Topics: Antifungal Agents; Candidiasis, Oral; Chronic Disease; Fluconazole; HIV Infections; Humans; Immune Tolerance; Itraconazole; Ketoconazole; Opportunistic Infections

1991
Chronic vulvovaginal candidosis: the role of oral treatment.
    British journal of clinical practice. Supplement, 1990, Volume: 71

    Topics: Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Female; Humans; Itraconazole; Ketoconazole; Recurrence

1990

Trials

17 trial(s) available for itraconazole and Chronic Disease

ArticleYear
Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India.
    The Lancet. Infectious diseases, 2022, Volume: 22, Issue:7

    Topics: Adult; Antifungal Agents; Chronic Disease; Female; Humans; India; Itraconazole; Male; Pulmonary Aspergillosis; Recurrence; Treatment Outcome

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea

2022
Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
    Mycoses, 2013, Volume: 56, Issue:5

    Topics: Adult; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Itraconazole; Male; Prospective Studies; Pulmonary Aspergillosis; Radiography, Thoracic; Treatment Outcome

2013
Efficacy of itraconazole in the treatment of patients with chronic cough whose sputa yield basidiomycetous fungi-fungus-associated chronic cough (FACC).
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2009, Volume: 46, Issue:4

    Topics: Adult; Aged; Antifungal Agents; Basidiomycota; Bronchodilator Agents; Chronic Disease; Cough; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Expectorants; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Mycoses; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Sputum; Statistics, Nonparametric; Treatment Outcome

2009
[An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2011, Volume: 85, Issue:6

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Capsules; Chronic Disease; Female; Humans; Injections, Intravenous; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis

2011
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    The American journal of medicine, 2006, Volume: 119, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole

2006
Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever.
    The Korean journal of internal medicine, 2006, Volume: 21, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Case-Control Studies; Chronic Disease; Female; Fever; Hematologic Neoplasms; Humans; Infusions, Intravenous; Itraconazole; Male; Neutropenia

2006
Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:3

    Topics: Adult; Antifungal Agents; Chronic Disease; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Leg; Male; Middle Aged; Nails; Onychomycosis; Prevalence; Treatment Outcome; Venous Insufficiency

2008
[Treatment of chronic human Chagas disease with itraconazole and allopurinol. Preliminary report].
    Revista medica de Chile, 1994, Volume: 122, Issue:4

    Topics: Adolescent; Adult; Allopurinol; Chagas Disease; Child; Chronic Disease; Drug Resistance; Electrocardiography; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Prognosis; Time Factors

1994
[Prerequisites for effective therapy of chronic recurrent vaginal candidiasis].
    Mycoses, 1996, Volume: 39 Suppl 1

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Child; Child, Preschool; Chronic Disease; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Recurrence

1996
Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis.
    Mycoses, 1997, Volume: 40, Issue:5-6

    Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Chronic Disease; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Follow-Up Studies; Humans; Itraconazole; Meningitis, Cryptococcal

1997
Treatment of chronic Chagas' disease with itraconazole and allopurinol.
    The American journal of tropical medicine and hygiene, 1998, Volume: 59, Issue:1

    Topics: Adolescent; Adult; Allopurinol; Animals; Antibodies, Protozoan; Antifungal Agents; Antimetabolites; Biological Assay; Chagas Cardiomyopathy; Chagas Disease; Child; Chronic Disease; Double-Blind Method; Electrocardiography; Follow-Up Studies; Humans; Insect Vectors; Itraconazole; Middle Aged; Nymph; Triatoma; Trypanosoma cruzi

1998
The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen.
    Dermatology (Basel, Switzerland), 2000, Volume: 200, Issue:2

    Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Humans; Itraconazole; Nails; Onychomycosis; Pilot Projects; Trichophyton

2000
Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study.
    Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:1

    Topics: Administration, Oral; Administration, Topical; Adult; Aged; Antifungal Agents; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Itraconazole; Male; Methylprednisolone; Middle Aged; Naphthalenes; Paronychia; Probability; Terbinafine; Treatment Outcome

2002
Itraconazole therapy for chronic coccidioidal meningitis.
    Annals of internal medicine, 1990, Jan-15, Volume: 112, Issue:2

    Topics: Adolescent; Adult; Aged; Antibodies, Fungal; Antifungal Agents; Chronic Disease; Coccidioidomycosis; Female; Humans; Itraconazole; Ketoconazole; Leukocyte Count; Male; Meningitis; Middle Aged; Multicenter Studies as Topic; Prospective Studies

1990
Itraconazole therapy in aspergillosis: study in 49 patients.
    Journal of the American Academy of Dermatology, 1990, Volume: 23, Issue:3 Pt 2

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Encephalitis; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Maxillary Sinusitis; Middle Aged; Recurrence

1990
The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987).
    Mycoses, 1988, Volume: 31, Issue:9

    Topics: Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Clinical Trials as Topic; Dermatomycoses; Granuloma; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Necrosis

1988

Other Studies

79 other study(ies) available for itraconazole and Chronic Disease

ArticleYear
A prospective study comparing itraconazole alone versus systemic steroids alone as adjuncts to topical steroids in the post-operative management of allergic fungal rhinosinusitis.
    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2023, Volume: 48, Issue:2

    Topics: Allergic Fungal Sinusitis; Antifungal Agents; Chronic Disease; Humans; Immunoglobulin E; Itraconazole; Methylprednisolone; Nasal Polyps; Prospective Studies; Quality of Life; Sinusitis

2023
A case report of long treatment with Itraconazole in a patient with chronic Chagas disease.
    BMC infectious diseases, 2019, Nov-09, Volume: 19, Issue:1

    Topics: Adult; Animals; CD4 Lymphocyte Count; Chagas Disease; Chronic Disease; Female; HIV Infections; Humans; Itraconazole; Tomography, X-Ray Computed; Trypanocidal Agents; Trypanosoma cruzi

2019
Algorithm-aided diagnosis of chronic pulmonary aspergillosis in low- and middle-income countries by use of a lateral flow device.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:1

    Topics: Adult; Algorithms; Anti-Retroviral Agents; Antifungal Agents; Antitubercular Agents; Aspergillus; Chronic Disease; Female; HIV Infections; Humans; Immunoglobulin G; Immunoglobulin M; Itraconazole; Poverty; Pulmonary Aspergillosis; Radiography, Thoracic; Tuberculosis, Pulmonary; Uganda

2020
Impact of high baseline Aspergillus-specific IgG levels on weight and quality-of-life outcomes of patients with chronic pulmonary aspergillosis.
    Medical mycology, 2020, Oct-01, Volume: 58, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergillus; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; United Kingdom; Voriconazole; Weight Loss

2020
Sarcoid-like cutaneous lesions in chronic adult paracoccidioidomycosis: report of two cases.
    Revista do Instituto de Medicina Tropical de Sao Paulo, 2017, Jun-01, Volume: 59

    Topics: Antifungal Agents; Chronic Disease; Humans; Itraconazole; Male; Middle Aged; Paracoccidioidomycosis; Sarcoidosis; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination

2017
Tinea corporis presenting as disseminated verrucous plaques caused by Arthroderma incurvatum in a young Indian boy.
    The Australasian journal of dermatology, 2017, Volume: 58, Issue:4

    Topics: Antifungal Agents; Arthrodermataceae; Child; Chronic Disease; Drug Therapy, Combination; Humans; India; Itraconazole; Male; Terbinafine; Tinea

2017
Image Gallery: Dermatophytic pseudomycetoma caused by Microsporum canis.
    The British journal of dermatology, 2018, Volume: 178, Issue:3

    Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Dermatomycoses; Female; Humans; Itraconazole; Microsporum; Treatment Outcome; Wrist; Young Adult

2018
[A case of histoplasmosis with chronic basilar meningitis diagnosed relatively early].
    Rinsho shinkeigaku = Clinical neurology, 2018, Apr-25, Volume: 58, Issue:4

    Topics: Adult; Amphotericin B; Antibodies, Fungal; Antifungal Agents; Biomarkers; Brain Stem; Cerebellum; Chronic Disease; Early Diagnosis; Histoplasma; Histoplasmosis; Humans; Immunocompetence; Itraconazole; Magnetic Resonance Imaging; Male; Meningitis, Fungal; Treatment Outcome; Tuberculosis, Pulmonary

2018
Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
    PloS one, 2018, Volume: 13, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Body Weight; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; Treatment Outcome; Voriconazole; Young Adult

2018
Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis.
    Assay and drug development technologies, 2018, Volume: 16, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Chronic Disease; Dose-Response Relationship, Drug; Female; Fluconazole; Humans; Itraconazole; Middle Aged; Phenylethyl Alcohol; Vulvovaginitis

2018
First case of chronic cutaneous chromoblastomycosis by Rhinocladiella similis aquired in Europe.
    Clinical and experimental dermatology, 2018, Volume: 43, Issue:8

    Topics: Antifungal Agents; Ascomycota; Chromoblastomycosis; Chronic Disease; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Treatment Outcome

2018
Central suppressant therapies in unexplained chronic cough patients whose sputum cultures yielded Bjerkandera adusta.
    Allergology international : official journal of the Japanese Society of Allergology, 2019, Volume: 68, Issue:1

    Topics: Adult; Air Pollution, Indoor; Antifungal Agents; Antitussive Agents; Chronic Disease; Coriolaceae; Cough; Drug Interactions; Female; Humans; Hypersensitivity; Itraconazole; Male; Medically Unexplained Symptoms; Middle Aged; Mycoses; Pregabalin; Sensation; Skin Tests; Sputum

2019
Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis.
    Medical mycology, 2013, Volume: 51, Issue:8

    Topics: Administration, Oral; Aged; Antifungal Agents; Chronic Disease; Female; Humans; Itraconazole; Male; Middle Aged; Mycobacterium Infections; Pulmonary Aspergillosis; Retrospective Studies; Treatment Outcome

2013
Chronic invasive sinus and intracerebral aspergillosis controlled by combination therapy with micafungin and a daily dose of 400 mg itraconazole oral solution.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:2

    Topics: Aged; Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Chronic Disease; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Micafungin; Paranasal Sinus Diseases; Radiography

2015
Chronic progressive disseminated histoplasmosis in a Mexican cockfighter.
    The American journal of tropical medicine and hygiene, 2015, Volume: 92, Issue:1

    Topics: Antifungal Agents; Chronic Disease; Histoplasmosis; Humans; Itraconazole; Male; Mexico; Middle Aged; Occupational Exposure

2015
Current therapeutic protocols for chronic granulomatous fungal sinusitis.
    Rhinology, 2015, Volume: 53, Issue:2

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Female; Granuloma; Humans; Itraconazole; Male; Middle Aged; Mycoses; Sinusitis; Treatment Outcome; Voriconazole

2015
Pulmonary Aspergillus Nodule--Still Challenging?
    Archivos de bronconeumologia, 2015, Volume: 51, Issue:11

    Topics: Antifungal Agents; Aspergillus fumigatus; Biopsy; Chemical and Drug Induced Liver Injury; Chronic Disease; Diagnosis, Differential; Drug Resistance, Fungal; Drug Substitution; Female; Hemoptysis; Humans; Itraconazole; Lung Neoplasms; Middle Aged; Pulmonary Aspergillosis; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Voriconazole

2015
Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.
    Mycoses, 2015, Volume: 58, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Chronic Disease; Delayed Diagnosis; Diagnostic Errors; Foot Dermatoses; Humans; Immunohistochemistry; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycetoma; Radiography; Scedosporium; Subcutaneous Tissue; Sudan; Voriconazole

2015
Chronic pulmonary aspergillosis: help is on the way.
    The Lancet. Respiratory medicine, 2016, Volume: 4, Issue:2

    Topics: Antifungal Agents; Chronic Disease; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Practice Guidelines as Topic; Pulmonary Aspergillosis; Voriconazole

2016
Management of chronic vulvovaginal candidiasis: a long term retrospective study.
    The Australasian journal of dermatology, 2017, Volume: 58, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Female; Fluconazole; Humans; Itraconazole; Maintenance Chemotherapy; Middle Aged; Remission Induction; Retrospective Studies; Time Factors; Young Adult

2017
Failure of itraconazole to prevent T-helper type 2 cell immune deviation: Implications for chronic rhinosinusitis.
    American journal of rhinology & allergy, 2016, Nov-01, Volume: 30, Issue:6

    Topics: Adolescent; Adult; Cell Differentiation; Cells, Cultured; Chronic Disease; Female; Humans; Immunologic Factors; Itraconazole; Lymphocyte Activation; Male; Middle Aged; Rhinitis; Sinusitis; Th1-Th2 Balance; Th2 Cells; Young Adult

2016
Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Chronic Disease; Female; Humans; Itraconazole; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pulmonary Aspergillosis; Retrospective Studies; Rifabutin

2017
[Case of chronic necrotizing pulmonary aspergillosis successfully treated with a combination of liposomal amphotericin B and itraconazole].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2008, Volume: 46, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Arthritis, Rheumatoid; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Drug Therapy, Combination; Humans; Itraconazole; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Treatment Outcome; Tuberculosis, Pulmonary

2008
Recombinant factor VIIa in massive haemoptysis associated with chronic necrotising aspergillosis.
    Collegium antropologicum, 2008, Volume: 32, Issue:3

    Topics: Antifungal Agents; Chronic Disease; Factor VIIa; Hemoptysis; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Recombinant Proteins; Treatment Outcome

2008
Chronic nonhealing ulcer of the right thumb with multiple subcutaneous nodules.
    Orthopedics, 2008, Volume: 31, Issue:7

    Topics: Antifungal Agents; Carcinoma, Basal Cell; Chronic Disease; Diagnosis, Differential; Humans; Itraconazole; Male; Middle Aged; Skin Neoplasms; Skin Ulcer; Sporotrichosis; Thumb; Treatment Failure; Treatment Outcome

2008
Antifungal treatment and chronic rhinosinusitis.
    Current allergy and asthma reports, 2009, Volume: 9, Issue:3

    Topics: Administration, Intranasal; Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Chronic Disease; Humans; Itraconazole; Mycoses; Rhinitis; Sinusitis

2009
Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas' disease.
    Chemotherapy, 2009, Volume: 55, Issue:4

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Chagas Disease; Chronic Disease; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Itraconazole; Male; Middle Aged; Trypanocidal Agents; Trypanosoma cruzi

2009
Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.
    Medical mycology, 2010, Volume: 48, Issue:2

    Topics: Aged; Antifungal Agents; Ascomycota; Chromoblastomycosis; Chronic Disease; Female; Histocytochemistry; Humans; Itraconazole; Thigh

2010
[Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Pulmonary Aspergillosis

2009
Diffuse alveolar hemorrhage following itraconazole injection.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:5

    Topics: Antifungal Agents; Chronic Disease; Hemoperfusion; Hemorrhage; Humans; Injections, Intravenous; Itraconazole; Lung Diseases; Male; Middle Aged; Polymyxin B; Pulmonary Aspergillosis

2010
Chronic monolateral otomycosis in a dog caused by Aspergillus ochraceus.
    Veterinary dermatology, 2010, Volume: 21, Issue:5

    Topics: Administration, Topical; Animals; Antifungal Agents; Aspergillosis; Aspergillus ochraceus; Chronic Disease; Dogs; Itraconazole; Male; Miconazole; Otitis Externa

2010
Chronic disseminated histoplasmosis with prolonged latency.
    The Journal of infection, 2010, Volume: 61, Issue:3

    Topics: Adrenal Glands; Aged, 80 and over; Chronic Disease; Fatal Outcome; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; Male; Reaction Time

2010
Histopathologic and immunologic effects of the itraconazole treatment in a murine model of chronic pulmonary paracoccidioidomycosis.
    Microbes and infection, 2010, Volume: 12, Issue:14-15

    Topics: Animals; Antifungal Agents; Chronic Disease; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Histocytochemistry; Itraconazole; Lung; Lung Diseases, Fungal; Mice; Mice, Inbred BALB C; Microscopy; Paracoccidioides; Paracoccidioidomycosis

2010
Peripheral neuropathy in patients on long-term triazole antifungal therapy.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:9

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cohort Studies; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2011
Chromoblastomycosis caused by Cladophialophora carrionii in a child from India.
    Journal of infection in developing countries, 2011, Jul-27, Volume: 5, Issue:7

    Topics: Antifungal Agents; Arm; Ascomycota; Child; Chromoblastomycosis; Chronic Disease; Histocytochemistry; Humans; India; Itraconazole; Male; Microscopy; Mycology; Naphthalenes; Terbinafine; Treatment Outcome

2011
[Erythematous exudative plaque in an elbow for 1 year].
    Enfermedades infecciosas y microbiologia clinica, 2012, Volume: 30, Issue:2

    Topics: Aged; Antifungal Agents; Chronic Disease; Elbow; Elbow Injuries; Erythema; Humans; Itraconazole; Male; Sporothrix; Sporotrichosis; Wound Infection

2012
Chronic multifocal paracoccidioidomycosis in an immunocompetent adult.
    Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:7

    Topics: Antifungal Agents; Chronic Disease; Facial Dermatoses; Foot Dermatoses; Hand Dermatoses; Humans; Immunocompetence; Itraconazole; Lip Diseases; Male; Middle Aged; Paracoccidioides; Paracoccidioidomycosis; Paraguay; Skin Ulcer

2012
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
    Medical mycology, 2013, Volume: 51, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
    Mycoses, 2013, Volume: 56, Issue:4

    Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
Paracoccidioidomycosis: report of 2 cases mimicking squamous cell carcinoma.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2002, Volume: 94, Issue:5

    Topics: Antifungal Agents; Carcinoma, Squamous Cell; Chronic Disease; Diagnosis, Differential; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Mexico; Middle Aged; Mouth Diseases; Paracoccidioidomycosis

2002
Combination of high-dose intravenous immunoglobulins and itraconozole in treating chronic mycotic demyelinating optic neuritis.
    TheScientificWorldJournal, 2003, Aug-02, Volume: 3

    Topics: Adult; Antifungal Agents; Autoantibodies; Chronic Disease; Demyelinating Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Environmental Exposure; Evoked Potentials, Visual; Female; Fungi; Humans; Immunoglobulins, Intravenous; Itraconazole; Mycotoxins; Optic Neuritis

2003
Use of polymerase chain reaction (PCR) and hybridization assays to detect Trypanosoma cruzi in chronic chagasic patients treated with itraconazole or allopurinol.
    Diagnostic microbiology and infectious disease, 2004, Volume: 48, Issue:4

    Topics: Adult; Allopurinol; Animals; Antiprotozoal Agents; Chagas Disease; Chronic Disease; Female; Humans; Itraconazole; Male; Nucleic Acid Hybridization; Polymerase Chain Reaction; Trypanosoma cruzi

2004
Successful treatment of chronic disseminated candidiasis with caspofungin and itraconazole in a patient with progressive acute leukemia and prolonged neutropenia.
    International journal of hematology, 2004, Volume: 79, Issue:3

    Topics: Adult; Antifungal Agents; Candidiasis; Caspofungin; Chronic Disease; Echinocandins; Female; Humans; Interleukin-2; Itraconazole; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Opportunistic Infections; Peptides; Peptides, Cyclic; Treatment Outcome

2004
Chronic necrotizing pulmonary aspergillosis complicated by pneumothorax.
    Infection, 2004, Volume: 32, Issue:4

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Humans; Itraconazole; Lung; Male; Middle Aged; Necrosis; Pneumothorax; Thoracic Surgery, Video-Assisted; Treatment Outcome

2004
Malignant mimickers: chronic bacterial and fungal infections of the larynx.
    Journal of voice : official journal of the Voice Foundation, 2005, Volume: 19, Issue:1

    Topics: Adult; Antifungal Agents; Botrytis; Carcinoma, Squamous Cell; Chronic Disease; Diagnosis, Differential; Histoplasmosis; Humans; Itraconazole; Laryngeal Diseases; Male; Mycoses; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections

2005
[Diagnosis and treatment of chronic pulmonary aspergillosis in 4 children].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2005, Volume: 43, Issue:2

    Topics: Amphotericin B; Child; Child, Preschool; Chronic Disease; Drug Therapy, Combination; Female; Humans; Infant; Itraconazole; Male; Pulmonary Aspergillosis

2005
Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment.
    Annals of tropical medicine and parasitology, 2005, Volume: 99, Issue:8

    Topics: Adult; Allopurinol; Animals; Arrhythmias, Cardiac; Chagas Disease; Chronic Disease; DNA, Protozoan; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Polymerase Chain Reaction; Trypanosoma cruzi; Xenodiagnosis

2005
Osteomyelitis resulting from chronic filamentous fungus olecranon bursitis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2005, Volume: 11, Issue:5

    Topics: Antifungal Agents; Bursitis; Chronic Disease; Elbow Joint; Female; Humans; Itraconazole; Middle Aged; Mycoses; Osteomyelitis

2005
Chronic postoperative endophthalmitis caused by Bipolaris australiensis.
    Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:1

    Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Cataract Extraction; Chronic Disease; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Itraconazole; Lenses, Intraocular; Mycoses; Postoperative Complications; Vitrectomy

2006
Chronic disseminated cutaneous histoplasmosis in an immunocompetent individual--a case report.
    International journal of dermatology, 2006, Volume: 45, Issue:5

    Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Dermatomycoses; Diagnosis, Differential; Edema; Female; Histoplasmosis; Humans; Itraconazole; Middle Aged; Tomography, X-Ray Computed; Ultrasonography

2006
[Micafungin therapy for a case of chronic necrotizing pulmonary aspergillosis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2006, Volume: 44, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Therapy, Combination; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Necrosis; Peptides, Cyclic

2006
The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
    SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging, 1999, Volume: 54, Issue:12

    Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Chemoprevention; Chronic Disease; Cohort Studies; Comprehensive Health Care; Female; Fluconazole; Follow-Up Studies; Heterosexuality; Humans; Itraconazole; Male; Miconazole; Middle Aged; Nystatin; Population Surveillance; Retrospective Studies; South Africa; Treatment Outcome

1999
Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
    Medical mycology, 2007, Volume: 45, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Peptides, Cyclic; Radiography; Retrospective Studies; Treatment Outcome

2007
[The treatment of vulvovaginal candidomycosis with itraconazole (Sporanox)].
    Akusherstvo i ginekologiia, 1994, Volume: 33, Issue:2

    Topics: Acute Disease; Administration, Oral; Candida; Candidiasis, Vulvovaginal; Chronic Disease; Drug Evaluation; Female; Humans; Itraconazole; Recurrence

1994
[A case of chronic necrotizing pulmonary aspergillosis treated with itraconazole].
    Nihon Kyobu Shikkan Gakkai zasshi, 1993, Volume: 31, Issue:9

    Topics: Administration, Oral; Aged; Aged, 80 and over; Aspergillosis; Chronic Disease; Female; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Necrosis; Tuberculosis, Pulmonary

1993
Chronic necrotizing pulmonary aspergillosis: pathologic outcome after itraconazole therapy.
    Mayo Clinic proceedings, 1996, Volume: 71, Issue:1

    Topics: Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Humans; Itraconazole; Male; Middle Aged; Necrosis

1996
[Chronic necrotizing pulmonary aspergillosis treated with itraconazole and inhaled amphotericin B].
    Nihon Kyobu Shikkan Gakkai zasshi, 1995, Volume: 33, Issue:10

    Topics: Administration, Inhalation; Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Therapy, Combination; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Necrosis; Tuberculosis, Pulmonary

1995
Use of itraconazole for treatment of sporotrichosis involving a knee prosthesis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:2

    Topics: Antifungal Agents; Arthritis, Infectious; Arthroplasty; Chronic Disease; Humans; Itraconazole; Knee Prosthesis; Male; Microbial Sensitivity Tests; Middle Aged; Prosthesis-Related Infections; Sporothrix; Sporotrichosis; Synovial Fluid

1995
Effect of combined antibacterial and antifungal treatment in severe atopic dermatitis.
    The Journal of allergy and clinical immunology, 1996, Volume: 98, Issue:3

    Topics: Adult; Allergens; Animals; Anti-Bacterial Agents; Antifungal Agents; Chronic Disease; Dermatitis, Atopic; Drug Therapy, Combination; Eosinophilia; Female; Humans; Itraconazole; Male; Middle Aged

1996
[Chronic semi-invasive aspergillosis with broncho-pleural fistula treated with itraconazole and surgically].
    Pneumonologia i alergologia polska, 1996, Volume: 64, Issue:7-8

    Topics: Antifungal Agents; Aspergillosis; Bronchial Diseases; Chronic Disease; Fistula; Humans; Itraconazole; Male; Middle Aged; Pleural Diseases

1996
Improvement of eumycetoma with itraconazole.
    Journal of the American Academy of Dermatology, 1997, Volume: 36, Issue:2 Pt 1

    Topics: Chronic Disease; Combined Modality Therapy; Drainage; Follow-Up Studies; Humans; Itraconazole; Mycetoma; Treatment Outcome

1997
Chronic cavitary pulmonary sporotrichosis: efficacy of oral itraconazole.
    The Journal of the Kentucky Medical Association, 1998, Volume: 96, Issue:3

    Topics: Administration, Oral; Antibodies, Fungal; Antifungal Agents; Chronic Disease; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Sporothrix; Sporotrichosis; Tomography, X-Ray Computed

1998
Effect of itraconazole on lytic antibodies levels in chronic Chagas disease.
    Parasite (Paris, France), 1997, Volume: 4, Issue:3

    Topics: Adult; Antibodies, Protozoan; Antifungal Agents; Chagas Disease; Child; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Itraconazole; Middle Aged

1997
[Serologic evaluation of treatment of chronic Chagas disease with allopurinol and itraconazole].
    Revista medica de Chile, 1998, Volume: 126, Issue:3

    Topics: Adolescent; Adult; Allopurinol; Antiprotozoal Agents; Chagas Disease; Child; Chronic Disease; Follow-Up Studies; Humans; Itraconazole; Middle Aged

1998
[Disseminated histoplasmosis detected by lingual and tonsillar erosions in an immunocompetent patient].
    Annales de dermatologie et de venereologie, 1999, Volume: 126, Issue:10

    Topics: Alcoholism; Antifungal Agents; Carcinoma, Squamous Cell; Chronic Disease; Diagnosis, Differential; Histoplasmosis; Humans; Immunocompetence; Itraconazole; Male; Middle Aged; Palatine Tonsil; Smoking; Tongue Diseases; Tongue Neoplasms; Tuberculosis, Pulmonary

1999
[Successful treatment of chronic necrotizing pulmonary aspergillosis with oral itraconazole long-term therapy].
    Deutsche medizinische Wochenschrift (1946), 1999, Nov-26, Volume: 124, Issue:47

    Topics: Administration, Oral; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Humans; Itraconazole; Long-Term Care; Lung Diseases, Fungal; Male; Tomography, X-Ray Computed

1999
Serum itraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus.
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2000, Volume: 41, Issue:1

    Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Chronic Disease; Digoxin; Drug Interactions; Humans; Itraconazole; Male; Meningitis, Fungal; Serum Albumin

2000
[Pulmonary aspergillosis complicating chronic septic granulomatosis. Treatment with itraconazole and gamma interferon].
    Revue des maladies respiratoires, 2000, Volume: 17, Issue:5

    Topics: Adult; Antifungal Agents; Aspergillosis; Chronic Disease; Cost-Benefit Analysis; Drug Costs; Granuloma; Humans; Interferon-gamma; Itraconazole; Lung Diseases, Fungal; Male; Prognosis; Sepsis; Treatment Outcome

2000
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
    Mycoses, 2000, Volume: 43 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole

2000
Chronic rhinosinusitis.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2001, Volume: 86, Issue:5

    Topics: Antifungal Agents; Chronic Disease; Drug Administration Schedule; False Positive Reactions; Fungi; Humans; Itraconazole; Mycoses; Rhinitis; Sinusitis

2001
Allergic fungal rhinosinusitis: report of 4 cases from Saudi Arabia.
    Saudi medical journal, 2000, Volume: 21, Issue:6

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Biopsy; Chronic Disease; Combined Modality Therapy; Debridement; Diagnosis, Differential; Female; Humans; Itraconazole; Male; Rhinitis, Allergic, Perennial; Saudi Arabia; Sinusitis; Tomography, X-Ray Computed; Treatment Outcome

2000
Thorn-induced Alternaria flexor tenosynovitis of the hand.
    The Pediatric infectious disease journal, 2001, Volume: 20, Issue:11

    Topics: Alternaria; Antifungal Agents; Child; Chronic Disease; Diagnosis, Differential; Finger Injuries; Humans; Itraconazole; Male; Synovial Membrane; Tenosynovitis; Wounds, Penetrating

2001
Chronic recurrent vaginal candidosis: easy to treat, difficult to cure. Results of intermittent treatment with a new oral antifungant.
    European journal of obstetrics, gynecology, and reproductive biology, 1990, Volume: 35, Issue:1

    Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Menstrual Cycle; Middle Aged; Recurrence

1990
Treatment of paracoccidioidomycosis with itraconazole.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1990, Volume: 28, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Child; Chronic Disease; Humans; Itraconazole; Ketoconazole; Lung; Male; Middle Aged; Paracoccidioidomycosis; Radiography

1990
Treatment of chronic murine chromoblastomycosis with the triazole SCH39304.
    The American journal of tropical medicine and hygiene, 1990, Volume: 42, Issue:6

    Topics: Animals; Antifungal Agents; Chromoblastomycosis; Chronic Disease; Disease Models, Animal; Female; Itraconazole; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron; Mitosporic Fungi; Skin; Triazoles

1990
Itraconazole in the management of chronic dermatophytosis.
    Journal of the American Academy of Dermatology, 1990, Volume: 23, Issue:3 Pt 2

    Topics: Adult; Aged; Antifungal Agents; Chronic Disease; Dermatomycoses; Drug Administration Schedule; Female; Fingers; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Toes

1990
Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
    Journal of the American Academy of Dermatology, 1990, Volume: 23, Issue:3 Pt 2

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Chronic Disease; Coccidioides; Coccidioidomycosis; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence

1990
Chronic necrotising pulmonary aspergillosis treated with itraconazole.
    Thorax, 1989, Volume: 44, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Chronic Disease; Humans; Itraconazole; Ketoconazole; Lung; Lung Diseases, Fungal; Male; Middle Aged; Radiography; Spondylitis, Ankylosing

1989
[Severe Aspergillus keratomycosis treated with itraconazole per os].
    Journal francais d'ophtalmologie, 1989, Volume: 12, Issue:4

    Topics: Administration, Oral; Adult; Anterior Chamber; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Corneal Diseases; Humans; Itraconazole; Ketoconazole; Male

1989